Press Releases December 13, 2013

December 10, 2013
EyeTechCare doubles the number of health care facilities in France with the EyeOP1 device
The EyeOp1 device is now available in ten centers across France, with this figure expected to double in 2014. More

December 9, 2013
Gimv leads Financing in One of Europe’s Largest Private Rounds for a Preclinical-Stage Biotech
CHF 42 million in a tranched Series B financing with an option to obtain an additional CHF 14 million that would increase the total amount of the financing round to CHF 56 million. More

December 6, 2013
GP Bullhound advises Newlisi on investment by Beautiful Mind Capital
GP Bullhound, the technology investment bank, has acted as the exclusive financial advisor to Newlisi S.p.A. on its latest financing round bringing in new investor Beautiful Mind Capital Ltd, a European-focused Chinese private equity fund. More

December 2, 2013
Iris Capital and Bpifrance invest EUR 10 million in Mister-Auto.com, the online car parts specialist
Iris Capital and Bpifrance announce a EUR 10 million equity investment in Mister-Auto.com. More

December 2, 2013
Telormedix Raises CHF 6 M ($ 6.6 M) in Series B Financing Round
Telormedix, a clinical stage biopharmaceutical company focused on TLR7 agonists in the treatment of cancer and inflammatory diseases, today announced that it has raised CHF 6 Million in an extension to its Series B financing from existing investors Aravis Venture (Zurich, Switzerland) and Proquest Investments (Princeton, USA). More

November 29, 2013
Adaptimmune appoints Dr Jonathan Knowles as Chairman of the Board
Adaptimmune, the T cell therapy company pioneering engineered T cell receptors for the treatment of cancer and infectious disease, today announced the appointment of Dr Jonathan Knowles as the new executive Chairman of the Board of Directors with immediate effect. Dr Knowles succeeds Nicholas Cross who has been Chairman of the company since foundation and will remain on the Board as Deputy Chairman. More

November 27, 2013
Bioaxial secures EUR 1.9 million (USD 2.7 million) in new funding
Bioaxial secures EUR 1.9 million (USD 2.7 million) in new funding to finance the commercialization of its first range of super-resolved fluorescence microscopy instruments. More

November 26, 2013
Bioxodes raises EUR 2.6 million to develop antithrombotic peptide derived from tick’s saliva
Bioxodes has full ownership of the patent following an agreement with the University of Brussels. More

November 26, 2013
Videocon d2h launches the first large volume ZigBee deployment in India with GreenPeak silicon
In presence of HRH Princess Astrid, during the Belgian Economic Mission in Mumbai, Videocon d2h and GreenPeak sign their contract. More